General Information of Synthetic Binding Protein (SBP) (ID: SBP000406)
SBP Name
Repebody anti-VEGF r-C2
Synonyms
Repebody r-C2
Molecular Weight 30.6 kDa
Thermal Denaturation TEMP 82 ℃
Design Method Traditional methods (Site-directed mutagenesis and/or Directed evolution)
Expression System Escherichia coli Origami B (DE3)
Selection Method Phage display
Highest Status Research
Sequence Length 272
SBP Sequence
>Repebody anti-VEGF r-C2
ETITVSTPIKQIFPDDAFAETIKANLKKKSVTDAVTQNELNSIDQIIAYQSDIKSVQGIQ
YLPNVRYLILLQNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQ
LQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKL
TQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLSEWINKHSGVVRN
SAGSVAPDSAKCSGSGKPVRSIICPTHHHHHH
3D Structure
Computationally Modelled Structure
Click to Save PDB File
Template Name PDBID 3RFS
Protein Scaffold Information of This SBP
Scaffold ID PS055
Scaffold Info
[1]
Scaffold Name Repebody
Scaffold Class Non-Antibody
Fold Type Alpha-Helices + Beta-Sheets + Loops
Binding Target(s) of This SBP (BTS)
BTS Name Details Mechanism Application Affinity Research Organization Ref
Vascular endothelial growth factor A
BTS Info
Inhibitor Age related macular degeneration [ICD-11: 9B75.0Z]; Diabetic retinopathy [ICD-11: 9B71.0Z]; Cancer metastasis [ICD-11: 2E2Z] Kd: 10.6 nM Korea Advanced Institute of Science and Technology (KAIST) [1]
References
1 Anti-Human VEGF Repebody Effectively Suppresses Choroidal Neovascularization and Vascular Leakage. PLoS One. 2016 Mar 25;11(3):e0152522.